PLATELET BIOGENESIS, INC
ClosedWATERTOWN, United States · Founded 2016 · $111.5M raised
- Headquarters
- WATERTOWN, Massachusetts
- Employees
- 1–10
- Founded
- 2016
- Website
- plateletbiogenesis.com
- Total Funding
- $111.5M
- Last Round
- $75.5M Series BNov 2021
- Rounds
- 3
About
Platelet BioGenesis is a Cambridge, Massachusetts biotech company developing the world's first donor-independent source of platelets from human induced pluripotent stem cells using a scalable, cGMP-compliant bioreactor process. Its PLTs+™ platform aims to address the chronic global platelet shortage for cancer patients, surgical patients, and others requiring transfusions. The company also develops designer platelet-based therapeutics to treat cancer and life-threatening diseases.
Summary
PLATELET BIOGENESIS, INC is a company based in WATERTOWN, United States, founded in 2016. It has raised $111.5M in total across 3 rounds, most recently a $75.5M Series B round in Nov 2021. Investors include Ziff Capital Partners, SymBiosis and K2 HealthVentures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
